Fallbasierte Vorstellung der S2e-Leitlinie Diagnostik und Therapie des benignen Prostatasyndroms (BPS)

• DOI: 10.1007/s00120-024-02327-1
• Publication Date: 2024-04-10T14:03:34Z
• Authors: Thomas Bschleipfer

Benign prostatic hyperplasia (BPH) is the most common disease of lower urinary tract in men. The prevalence increases continuously with increasing age and a chronic progressive course to be expected. In order reduce morbidity affected patients improve their quality life, expert panel Prostatic Hyperplasia German Society Urology (DGU) has written new version evidence-based "S2e guideline on diagnosis treatment BPH". Using current patient case, contents S2e are illustrated, from decision-making process for suitable choice. case presented here shows possible complexity difficulty that can arise BPH, need further diagnostic steps finding therapy fulfill patient's wishes, if possible.